From: Becker's Supply Chain Report <editorial@beckershealthcare.com>
Subject: FDA scolds pharma lab for operating microbrewery in drug testing space | Amazon-JPMorgan-Berkshire venture hires consulting giant | Novo Nordisk cuts 400 jobs | PBM lobby names CEO with Capitol Hill ties
Preheader:
Reply: editorial@beckershealthcare.com
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube


September 21, 2018
TODAY'S TOP STORIES
1. FDA scolds pharmaceutical lab for operating microbrewery in drug testing space 
 
2. Amazon-JPMorgan-Berkshire venture hires consulting firm: 3 things to know  Full story

3. Novo Nordisk to lay off 400 employees  Full story

4. 3 takeaways from AHRMM's Supply Chain Conference. 

5. PBM lobby selects new chief with government ties: 5 things to know 

6. Steward closes Ohio hospital, lays off 468  Full story
 
7. Register for this webinar to learn how Mount Sinai Health System and Children's National Medical Center are driving strategic growth with an enterprise laboratory.

8. Physicians' choice: Best hospitals for treating key conditions
 
9. Amazon, Merck, Accenture to launch data-driven drug development platform  Full story
 
10. Drugmakers faced manufacturing dilemma during Hurricane Florence: 3 things to know  Full story
  
11. Ready to confront the financial risk of value-based purchasing? Download this whitepaper to learn how to improve the patient experience with healthcare's new digital front door.

12. A drug for migraine relief, a medical device for blood vessel tears & more: 4 latest FDA approvals 


Channels
Contact Us

Editorial Contact: 
Molly Gamble 
Editor-in-Chief
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO
 
Becker's Hospital Review
A Becker's Healthcare Publication
  www.BeckersHospitalReview.com
editorial@beckershealthcare.com
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
Sent by editorial@beckershealthcare.com in collaboration with
Constant Contact